FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Tropel

Research Profile

Chemicals & Drugs

Concepts & Ideas

Molecular Sequence Data

Procedures

Electrophoretic Mobility Shift Assay

Physiology

Phenomena

DNA Footprinting

Living Beings

Objects

Nanoparticles

Genes & Molecular Sequences

Genes, Reporter

Co-author Network

Publications

TOP 3
Maxime Quebatte; Michaela Dehio; David Tropel; Andrea Basler; Isabella Toller; Guenter Raddatz; Philipp Engel; Sonja Huser; Hermine Schein; Hillevi L Lindroos; Siv G E Andersson; Christoph Dehio
The BatR/BatS two-component regulatory system controls the adaptive response of Bartonella henselae during human endothelial cell infection.
Stephen A Kaba; Clara Brando; Qin Guo; Christian Mittelholzer; Senthilkumar Raman; David Tropel; Ueli Aebi; Peter Burkhard; David Lanar
A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malaria.
Ulrich Schroeder; Alexandra Graff; Sabine Buchmeier; Per Rigler; Unai Silvan; David Tropel; Brigitte M Jockusch; Ueli Aebi; Peter Burkhard; Cora-Ann Schoenenberger
Peptide nanoparticles serve as a powerful platform for the immunogenic display of poorly antigenic actin determinants.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Tropel (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Maxime Quebatte; Michaela Dehio; David Tropel; Andrea Basler; Isabella Toller; Guenter Raddatz; Philipp Engel; Sonja Huser; Hermine Schein; Hillevi L Lindroos; Siv G E Andersson; Christoph Dehio
The BatR/BatS two-component regulatory system controls the adaptive response of Bartonella henselae during human endothelial cell infection.
Journal of bacteriology 2010;192(13):3352-67.
2009: Stephen A Kaba; Clara Brando; Qin Guo; Christian Mittelholzer; Senthilkumar Raman; David Tropel; Ueli Aebi; Peter Burkhard; David Lanar
A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malaria.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(11):7268-77.
2009: Ulrich Schroeder; Alexandra Graff; Sabine Buchmeier; Per Rigler; Unai Silvan; David Tropel; Brigitte M Jockusch; Ueli Aebi; Peter Burkhard; Cora-Ann Schoenenberger
Peptide nanoparticles serve as a powerful platform for the immunogenic display of poorly antigenic actin determinants.
Journal of molecular biology 2009;386(5):1368-81.
2005: David Tropel; Jan Roelof van der Meer
Characterization of HbpR binding by site-directed mutagenesis of its DNA-binding site and by deletion of the effector domain.
The FEBS journal 2005;272(7):1756-66.
2004: David Tropel; Alexandra Bähler; Kathrin Globig; Jan Roelof van der Meer
Design of new promoters and of a dual-bioreporter based on cross-activation by the two regulatory proteins XylR and HbpR.
Environmental microbiology 2004;6(11):1186-96.
2004: Jan Roelof van der Meer; David Tropel; Marco C M Jaspers
Illuminating the detection chain of bacterial bioreporters.
Environmental microbiology 2004;6(10):1005-20.
2004: David Tropel; Jan Roelof van der Meer
Bacterial transcriptional regulators for degradation pathways of aromatic compounds.
Microbiology and molecular biology reviews : MMBR 2004;68(3):474-500, table of contents.
2002: David Tropel; Jan Roelof van der Meer
Identification and physical characterization of the HbpR binding sites of the hbpC and hbpD promoters.
Journal of bacteriology 2002;184(11):2914-24.